Cargando…
USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Editora Ltda.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604050/ http://dx.doi.org/10.1016/j.htct.2020.10.954 |
| _version_ | 1783604056605851648 |
|---|---|
| author | Senegaglia, A.C. Rebelatto, C.L.K. Franck, C.L. Lima, J.S. Daga, D.R. Shigunov, P. Azambuja, A.P. Bana, E.G. Dominguez, A.C. Brofman, P.R.S. |
| author_facet | Senegaglia, A.C. Rebelatto, C.L.K. Franck, C.L. Lima, J.S. Daga, D.R. Shigunov, P. Azambuja, A.P. Bana, E.G. Dominguez, A.C. Brofman, P.R.S. |
| author_sort | Senegaglia, A.C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7604050 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier Editora Ltda. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76040502020-11-02 USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO Senegaglia, A.C. Rebelatto, C.L.K. Franck, C.L. Lima, J.S. Daga, D.R. Shigunov, P. Azambuja, A.P. Bana, E.G. Dominguez, A.C. Brofman, P.R.S. Hematol Transfus Cell Ther 952 Published by Elsevier Editora Ltda. 2020-11 2020-10-31 /pmc/articles/PMC7604050/ http://dx.doi.org/10.1016/j.htct.2020.10.954 Text en Copyright © 2020 Published by Elsevier Editora Ltda. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | 952 Senegaglia, A.C. Rebelatto, C.L.K. Franck, C.L. Lima, J.S. Daga, D.R. Shigunov, P. Azambuja, A.P. Bana, E.G. Dominguez, A.C. Brofman, P.R.S. USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title | USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title_full | USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title_fullStr | USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title_full_unstemmed | USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title_short | USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO |
| title_sort | uso combinado de tocilizumabe e células-tronco mesenquimais no tratamento da covid-19 – relato de caso |
| topic | 952 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604050/ http://dx.doi.org/10.1016/j.htct.2020.10.954 |
| work_keys_str_mv | AT senegagliaac usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT rebelattoclk usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT franckcl usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT limajs usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT dagadr usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT shigunovp usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT azambujaap usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT banaeg usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT dominguezac usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso AT brofmanprs usocombinadodetocilizumabeecelulastroncomesenquimaisnotratamentodacovid19relatodecaso |